Safety and efficacy of lanreotide depot/autogel (LAN) in patients with lung NETs: The randomized, double-blind, placebo (PBO)-controlled phase III SPINET study.

Diane Lauren Reidy,Matthew H. Kulke,Edward M. Wolin,Simron Singh,Diego Ferone,Beloo Mirakhur,Christine Massien,Aude Houchard,Martyn Caplin,Eric Baudin

Safety and efficacy of lanreotide depot/autogel (LAN) in patients with lung NETs: The randomized, double-blind, placebo (PBO)-controlled phase III SPINET study.

2016

Diane Lauren Reidy
Matthew H. Kulke
Edward M. Wolin
Simron Singh
Diego Ferone
Beloo Mirakhur
Christine Massien
Aude Houchard
Martyn Caplin
Eric Baudin

TPS8580Background: In the CLARINET study (NCT00353496), LAN was associated with significantly prolonged progression-free survival (PFS) in patients with metastatic gastroenteropancreatic neuroendoc...

Keywords:

Lanreotide
Placebo
Physical therapy
Depot
Medicine
in patient
Gastroenterology
Internal medicine
Lung
double blind

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations